SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001669191-22-000021
Filing Date
2022-01-05
Accepted
2022-01-05 10:58:29
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 10081
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 119213
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 2560854
4 CPA REVIEW REPORT reviewletter.pdf EX-99 178293
5 CERTIFICATE OF INCORPORATION certificateofincorporation.pdf EX-99 4013072
6 CORPORATE BYLAWS corporatebylaws.pdf EX-99 10026208
7 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 150743
8 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 244
  Complete submission text file 0001669191-22-000021.txt   23493233
Mailing Address 237 KEARNY STREET STE. 9171 SAN FRANCISCO CA 94108
Business Address 237 KEARNY STREET #9171 SAN FRANCISCO CA 94108 8664151001
Bioverge, Inc. (Filer) CIK: 0001828649 (see all company filings)

IRS No.: 822592905 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C/A | Act: 33 | File No.: 020-27997 | Film No.: 22509880